NDAINJECTIONINJECTABLE
Approved
May 1973
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 3h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SELENOMETHIONINE SE-75 is a radioactive diagnostic agent administered by injection, used for imaging and diagnostic purposes in nuclear medicine. The product contains selenium-75, a radioisotope that enables visualization of organ function and pathology. It represents a legacy diagnostic modality in the nuclear medicine portfolio.
LOE Approaching
Product approaching loss of exclusivity with minimal commercial footprint; limited team expansion or ongoing support expected.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on SELENOMETHIONINE SE-75 offers limited career growth due to its LOE-approaching status and minimal linked job openings. Roles focus on compliance, supply management, and harvest optimization rather than innovation or expansion.
Product Manager (Diagnostics)Regulatory Affairs Specialist
Worked on SELENOMETHIONINE SE 75 at PharmaLundensis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.